9 Meters Biopharma, Inc. Announces Research & Development Day on Short Bowel Syndrome
SAVE THE DATE: Webinar Scheduled for March 23, 2021 @ 11 AM ET RALEIGH, NC / ACCESSWIRE / February 1,...
Staff
Kadmon Announces Publication of Preclinical Data Demonstrating Anti-PD-L1/IL-15 Fusion Protein KD033 Achieves Robust Anti-Tumor Response
NEW YORK, NY / ACCESSWIRE / February 1, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced the publication of preclinical...
Pharma-Bio Serv Announces Results for the Year Ended October 31, 2020
DORADO, PUERTO RICO / ACCESSWIRE / February 1, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), is...
Theralase(R) Releases Quarterly Newsletter
TORONTO, ON / ACCESSWIRE / February 1, 2021 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
Sonnet BioTherapeutics Completes Successful Repeat Dose Study of SON-1010 in Non-Human Primates
The toxicity effects of SON-1010 were well tolerated at doses exceeding levels expected in future human clinical trials, without producing...
Lexaria Provides Guidance on Upcoming R&D
KELOWNA, BC / ACCESSWIRE / February 1, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator...
Genesys Industries, Inc. Corporate Update
CALGARY, ALBERTA, Feb. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Genesys Industries, Inc. (OTC Pink: GEIN) (the “Company”) is...
National Basketball Retired Players Association, Sheryl Swoopes and Flexion Therapeutics Announce Partnership to Raise Awareness of ZILRETTA®
- Sheryl Swoopes, WNBA Legend, Basketball Hall of Famer and ZILRETTA Patient, Tips Off Educational Campaign About ZILRETTA and Osteoarthritis Knee...
Chiesi Group receives the European Marketing authorization for the extrafine triple-combination therapy for the treatment of moderate to severe asthma
It is the first extrafine fixed triple combination therapy in a single inhaler to be approved for use in asthma...
ATEC Opens New Headquarters with Substantially Increased Sales and Surgeon Education Capacity
CARLSBAD, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative spine surgery solutions...
SetPoint Medical Announces First Patient Enrolled in the RESET-RA Study
Pivotal IDE Study will evalute SetPoint’s propriertary bioelectronic device for treatment of Rheumatoid ArthritisVALENCIA, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE)...
Protech Home Medical Reports Strong Fourth Quarter and Record Audited Full Year Fiscal 2020 Financial Results
Posts Q4 Revenue Growth of 28% and Adjusted EBITDA Growth of 69%CINCINNATI, Ohio, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Protech...
Philips expands remote patient management with the introduction of Medical Tablet with advanced software
Philips Medical Tablet Physicians Consult with Philips Medical Tablet February 1, 2021 New solution available in North America, Europe and...
BBS-Bioactive Bone Substitutes Plc: CFO will change on 1 February, 2021
BBS-Bioactive Bone Substitutes Plc, Company Announcement on 1 February 2021 at 3:35 pm (UTC +2:00) MSc. (Tech) Liisa Hukka from...
PureK Holdings Corp., a Plant-Based Wellness Company, Signs Definitive Agreement to Acquire No B.S. Skincare, a Clean Ingredient Skincare Company
No B.S. Brands No B.S. Skincare No B.S. Skincare Products to Become Available on Target.com Beginning in February 2021 VANCOUVER,...
Pfizer and BioNTech Publish Preclinical Data from Investigational COVID-19 Vaccine Program in Nature
New York, NY and Mainz, Germany, February 1, 2021 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq:...
Nova Leap Health Corp. to Force Conversion of 8% Convertible Debentures due December 30, 2024
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Feb. 01, 2021...
Zosano Pharma Presents Early-Onset of Action Data for Qtrypta™ in Acute Treatment of Migraines
Review of data from the ZOTRIP trial suggest that Qtrypta showed therapeutic gain at 30 minutes consistent with recently published...
Vaxil Appoints a Special Advisor to the Board of Directors
FURTHER UPDATE ON USAMRIID CHALLENGE AND ADDITIONAL EUROPEAN PATENT GRANTED FOR VAXIL’S ANTICANCER ANTIBODY PLATFORM Not for distribution by US...
Vystar Issues Corporate Update on Strategic Initiatives and the Impact of COVID-19 on Brands
RxAir 400 RxAir 400 UV-C light air purifiers destroy more than 99.9% of airborne viruses and bacteria, and are ideal...